Text Size
144 studies found for:    {(lung cancer) [CONDITION] (gene therapy) [TREATMENT]}

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Not yet recruiting Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Surgery combined with rAd-p53 gene therapy;   Procedure: Surgery
2 Unknown † Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region
Condition: Lung Cancer
Interventions: Genetic: genetic linkage analysis;   Genetic: loss of heterozygosity analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: biologic sample preservation procedure;   Other: medical chart review;   Other: questionnaire administration;   Procedure: evaluation of cancer risk factors
3 Completed Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery
Condition: Lung Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: vinorelbine ditartrate;   Genetic: cytogenetic analysis;   Genetic: loss of heterozygosity analysis;   Genetic: microarray analysis;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
4 Active, not recruiting Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Adenosquamous Cell Lung Cancer;   Bronchoalveolar Cell Lung Cancer;   Large Cell Lung Cancer;   Non-small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Squamous Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: cisplatin;   Biological: pegfilgrastim;   Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis;   Genetic: polymorphism analysis;   Other: pharmacogenomic studies;   Genetic: genetic linkage analysis;   Drug: docetaxel
5 Active, not recruiting Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: pegfilgrastim;   Drug: cisplatin;   Drug: docetaxel;   Drug: erlotinib hydrochloride;   Genetic: genetic linkage analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies
6 Completed Predictive Genetic Risk Assessment Trial
Conditions: Colon Cancer;   Lung Cancer;   Atrial Fibrillation;   Diabetes Type 2;   Obesity;   Breast Cancer;   Graves Disease;   Osteoarthritis;   Celiac Disease;   Myocardial Infarction;   Prostate Cancer
Intervention: Genetic: SNP analysis
7 Unknown † Liverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung Cancer
Conditions: Health Status Unknown;   Lung Cancer
Interventions: Genetic: DNA methylation analysis;   Genetic: DNA stability analysis;   Genetic: gene expression analysis;   Other: epidemiologic study;   Other: study of socioeconomic and demographic variables;   Procedure: biopsy;   Procedure: evaluation of cancer risk factors;   Procedure: study of high risk factors
8 Recruiting Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
Conditions: Anal Cancer;   Cervical Cancer;   Lung Cancer;   Lymphoma;   Nonneoplastic Condition
Interventions: Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: gene expression analysis;   Genetic: polymorphism analysis;   Other: biologic sample preservation procedure;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Other: medical chart review
9 Not yet recruiting Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy
Conditions: Stage IA Non-small Cell Lung Cancer;   Stage IB Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer
Interventions: Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: Fourier transform ion cyclotron resonance mass spectrometry;   Other: medical chart review;   Other: laboratory biomarker analysis
10 Active, not recruiting Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: celecoxib;   Other: placebo;   Other: laboratory biomarker analysis;   Other: immunohistochemistry staining method;   Genetic: fluorescence in situ hybridization;   Genetic: mutation analysis;   Genetic: protein expression analysis;   Genetic: gene expression analysis
11 Recruiting Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507
Condition: Lung Cancer
Interventions: Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: laboratory biomarker analysis
12 Unknown † Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
Condition: Lung Cancer
Interventions: Genetic: comparative genomic hybridization;   Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: protein expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: matrix-assisted laser desorption/ionization time of flight mass spectrometry;   Other: medical chart review;   Procedure: diagnostic bronchoscopy
13 Unknown † Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Genetic: chromogenic in situ hybridization;   Genetic: gene expression analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: fluorescent antibody technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: matrix-assisted laser desorption/ionization time of flight mass spectrometry;   Other: study of socioeconomic and demographic variables;   Procedure: study of high risk factors
14 Unknown † Cancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030
Condition: Lung Cancer
Interventions: Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: polymorphism analysis
15 Recruiting Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Genetic: DNA analysis;   Genetic: DNA methylation analysis;   Genetic: RNA analysis;   Genetic: gene expression analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: medical chart review
16 Unknown † Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy
Condition: Lung Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: sorafenib tosylate;   Genetic: DNA analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: protein analysis;   Genetic: protein expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
17 Not yet recruiting Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
Condition: Lung Cancer
Interventions: Genetic: DNA analysis;   Genetic: gene expression analysis;   Genetic: gene mapping;   Genetic: mutation analysis;   Other: laboratory biomarker analysis
18 Not yet recruiting Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Genetic: RNA analysis;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: laboratory biomarker analysis;   Other: medical chart review
19 Completed Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
Conditions: Lung Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bortezomib;   Drug: pemetrexed disodium;   Genetic: gene expression analysis;   Genetic: mutation analysis;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: flow cytometry;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method
20 Unknown † DNA Analysis of Blood and Tissue From Patients With Lung Cancer
Condition: Lung Cancer
Interventions: Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: diagnostic laboratory biomarker analysis
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years